Press release
Oligodendroglioma Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Eilly Lilly, Spring Work Therapeutics
Oligodendroglioma Market
Download Sample Report to know more: https://www.delveinsight.com/sample-request/oligodendroglioma-market?utm_source=benzinga&utm_medium=pressrelease&utm_campaign=dpr
Oligodendroglioma Overview
Oligodendrogliomas is a rare type of brain tumor that develops from glial cells called oligodendrocytes. It is more common in adults than in children. They often involve the cortical gray matter and are most commonly seen in the frontal lobes. Oligodendrogliomas are generally low-grade WHO grade II neoplasms that are slow-growing tumors and have a favorable treatment response when compared to other gliomas. Whereas Grade III anaplastic oligodendroglioma is a more malignant form of the tumor that portends a less favorable prognosis and may occur de novo or as degeneration from the lower grade oligodendroglioma.
Clinically, patients with oligodendroglioma most often present with non-specific symptoms such as headache. However, seizures are also a very common presenting symptom and are reported in 35-85% of individuals, with some studies as high as 91% of participants. Occasionally patients will have focal neurological deficits based on tumor location. Any patient with new seizures or focal neurological deficits should undergo CNS imaging. Historically oligodendroglioma was diagnosed based on the histological appearance of the tumor. It shares many imaging characteristics with other astrocytomas, and tissue sampling is essential in diagnosis. It is defined by its IDHmt and 1p/19q deletion status and several imaging features that suggest oligodendroglioma as opposed to astrocytoma including course calcification and cortical-subcortical location. Often, non-contrast-enhanced computed tomography (NECT) is the initial imaging tool for nonspecific neurologic symptoms.
Click here to learn more about the Oligodendroglioma Market Landscape@
https://www.delveinsight.com/report-store/oligodendroglioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlight from Oligodendroglioma Market Report
Key Companies working in Oligodendroglioma Market include Servier, Eli Lilly, SpringWorks Therapeutics, EpicentRx, and many others.
Key Therapies in Oligodendroglioma include Vorasidenib, VERZENIO, Mirdametinib, RRx-001, and many others.
Oligodendroglioma Treatment Market
Treatment depends on whether the oligodendroglioma is low grade (slow-growing) or high grade (fast growing). The main treatments for oligodendroglioma are surgery to remove as much tumor as possible. radiotherapy, which uses high-energy X-rays to destroy cancer cells.
Learn more about the treatment market for Oligodendroglioma @ https://www.delveinsight.com/report-store/oligodendroglioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Oligodendroglioma Epidemiology Segmented by:
Oligodendroglioma prevalent cases
Oligodendroglioma incident cases
Oligodendroglioma diagnosed cases
Oligodendroglioma treatment cases
Oligodendroglioma Drug Profile and Companies Covered
Eli Lilly: DOTATOC
SpringWorks Therapeutics: Abatacept
And many others.
Learn more about the Key Companies and Emerging Therapies in the Oligodendroglioma Market @ https://www.delveinsight.com/report-store/oligodendroglioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Oligodendroglioma Introduction
Executive Summary of Oligodendroglioma
Disease Background and Overview
Oligodendroglioma Epidemiology and patient population
Oligodendroglioma Emerging Therapies
Oligodendroglioma Market Outlook
Oligodendroglioma Market Access and Reimbursement of Therapies
Oligodendroglioma Market Drivers
Oligodendroglioma Market Barriers
Appendix
Oligodendroglioma Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the Oligodendroglioma Market Outlook report @ https://www.delveinsight.com/report-store/oligodendroglioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports
Oligodendroglioma Epidemiology Forecast
https://www.delveinsight.com/report-store/oligodendroglioma-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Oligodendroglioma Pipeline Forecast
https://www.delveinsight.com/report-store/oligodendroglioma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Trending Reports
Functional Constipation Market
https://www.delveinsight.com/report-store/functional-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market
https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Epidemiology https://www.delveinsight.com/report-store/immune-thrombocytopenic-purpura-epidemiology-forecast
Visceral Pain Associated with GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Nosocomial Pneumonia Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin Dependent Kinase like 5 Deficiency Disorder Market
https://www.delveinsight.com/report-store/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Ocular Hypertension Market
https://www.delveinsight.com/report-store/Ocular Hypertension -market
Ocular inflammation and Pain Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger Ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-Related Hearing Loss Medical Device
https://www.delveinsight.com/report-store/age-related-hearing-loss-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/ Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive DisorderMarket
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid Lipofuscinosis Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oligodendroglioma Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Eilly Lilly, Spring Work Therapeutics here
News-ID: 3174149 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Oligodendroglioma
Oligodendroglioma Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Oligodendroglioma is a type of brain tumor that arises from oligodendrocytes, the cells responsible for producing myelin, which insulates nerve fibers in the brain. Oligodendrogliomas are classified as gliomas, which are tumors originating in the glial cells of the brain. These tumors can occur in various parts of the brain, but are most commonly found in the frontal lobe and temporal lobe. Unlike other forms of glioma, oligodendrogliomas are generally…
Oligodendroglioma Market Analysis, Emerging Therapies and Strategic Forecast
Oligodendroglioma is a rare and aggressive type of brain cancer that originates in the oligodendrocyte cells, which are responsible for producing the protective covering (myelin) of nerve fibers in the brain and spinal cord. Oligodendrogliomas account for approximately 2-5% of all primary brain tumors and are most commonly diagnosed in young adults. These tumors are particularly challenging to treat due to their invasive nature, resistance to traditional therapies, and often,…
Oligodendroglioma Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) DelveInsight's "Oligodendroglioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oligodendroglioma, historical and forecasted epidemiology as well as the Oligodendroglioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Oligodendroglioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Oligodendroglioma market size from 2019 to 2032,…
Oligodendroglioma Market to Witness Growth by 2032 | Companies- EpicentRx, Pfize …
DelveInsight's "Oligodendroglioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oligodendroglioma, historical and forecasted epidemiology as well as the Oligodendroglioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Oligodendroglioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Oligodendroglioma market size from 2019 to 2032, segmented…
DelveInsight Evaluates a Robust Oligodendroglioma Pipeline as 10+ Influential Ph …
DelveInsight's, "Oligodendroglioma Pipeline Insight, 2023," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Oligodendroglioma pipeline landscape. It covers the Oligodendroglioma pipeline drug profiles, including Oligodendroglioma clinical trials and nonclinical stage products. It also covers the Oligodendroglioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
For Oligodendroglioma emerging drugs, the Oligodendroglioma…
Oligodendroglioma - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Oligodendroglioma - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma - Pipeline Review, H1 2017, provides an overview of the Oligodendroglioma (Oncology) pipeline landscape.
Oligodendroglioma is a type of glioma (primary glial brain tumor). They often contain mineral deposits (called calcifications), areas of hemorrhage, and/or cysts.…
